China Universal Asset Management Company’s Immuneering IMRX Stock Holding History

China Universal Asset Management Company’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63.9K	Buy	12,797 +1,339	+12%	+$6.77K	﹤0.01%	446
2026 Q1	$60.4K	Sell	11,458 -4,064	-26%	-$20.8K	﹤0.01%	447
2025 Q4	$102K	Buy	15,522 +10,522	+210%	+$67.6K	0.01%	408
2025 Q3	$35K	Buy	+5,000	New	+$25.9K	﹤0.01%	448
2023 Q4	–	Sell	-749	Closed	-$5.75K	–	455
2023 Q3	$5.75K	Buy	749 +366	+96%	+$3.37K	﹤0.01%	381
2023 Q2	$3.88K	Buy	383 +25	+7%	+$240	﹤0.01%	390
2023 Q1	$3.48K	Buy	358 +90	+34%	+$511	﹤0.01%	404
2022 Q4	$1.3K	Buy	268 +21	+9%	+$186	﹤0.01%	387
2022 Q3	$4K	Buy	+247	New	+$1.96K	﹤0.01%	299

Other funds holding IMRX

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

FCC

Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Berman McAleer Timonium, Maryland $864M AUM 22.02% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

NFG

Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

China Universal Asset Management Company's IMRX Position: Q2 2026 in Review

China Universal Asset Management Company increased its Immuneering (IMRX) stake by 12% in Q2 2026, buying an estimated $6.77K and bringing the position to 12,797 shares worth $63.9K. The position accounts for ﹤0.01% of the portfolio, ranked #446.

China Universal Asset Management Company first reported a position in IMRX in Q3 2022 and has held it in 9 quarters since. The position peaked at $102K in Q4 2025. 21 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

China Universal Asset Management Company held 12,797 shares of Immuneering worth $63.9K as of Q2 2026.
China Universal Asset Management Company bought 1,339 Immuneering shares in Q2 2026, an estimated $6.77K.
Immuneering made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #446 holding.
China Universal Asset Management Company first reported a position in Immuneering in Q3 2022 and has held it in 9 quarters since.
China Universal Asset Management Company's Immuneering position peaked at $102K in Q4 2025.
21 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.